| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Interest Income | 32,619,614 | -15.002% | 38,376,991 | 43,348,175 | 40,915,676 | 42,533,959 |
| Interest Expense | (25,732,939) | -12.801% | (29,510,750) | (30,494,491) | (28,528,067) | (27,975,598) |
| Net Interest Income | 6,886,675 | -22.327% | 8,866,241 | 12,853,684 | 12,387,609 | 14,558,361 |
| Other Operating Income | 1,689,976 | 44.001% | 1,173,584 | 3,299,427 | 3,079,002 | 1,708,452 |
| Total Operating Income | 8,576,651 | -14.574% | 10,039,825 | 16,153,111 | 15,466,611 | 16,266,813 |
| Net Insurance Claims Incurred & Movement in Policyholders' Liabilities | 0 | -- | 0 | 0 | 0 | 0 |
| Net Operating Income | 8,576,651 | -14.574% | 10,039,825 | 16,153,111 | 15,466,611 | 16,266,813 |
| Operating Expenses | (5,859,448) | -2.340% | (5,999,866) | (5,790,240) | (5,855,054) | (5,050,086) |
| Impairment Losses on Loans & Advances | (1,478,008) | 42.646% | (1,036,135) | (5,644,350) | (6,948,475) | (8,328,608) |
| Other Impairment Losses | (268,902) | -87.093% | (2,083,459) | (3,527,272) | (2,559,487) | (2,296,755) |
| Operating Profit / (Loss) | 970,293 | 5.425% | 920,365 | 1,191,249 | 103,595 | 591,364 |
| Change in FV & Impairment on Inv. Prop. | 0 | -- | 0 | 0 | 0 | 0 |
| Change in FV & Impairment on Others | 0 | -- | 0 | 0 | 0 | 0 |
| Profit / (Loss) on Disposal | 0 | -- | 0 | 0 | 0 | 0 |
| Other Non-operating Items | 0 | -- | 0 | 0 | 0 | 0 |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 |
| Profit / (Loss) before Taxation | 970,293 | 5.425% | 920,365 | 1,191,249 | 103,595 | 591,364 |
| Taxation | (326,865) | 110.059% | (155,606) | (171,980) | 327,288 | 640,577 |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- |
| Non-controlling Interests | (22,378) | -30.772% | (32,325) | (39,371) | (28,922) | (28,164) |
| Others | -- | -- | -- | -- | -- | -- |
| Profit / (Loss) Attributable to Shareholders | 621,050 | -15.207% | 732,434 | 979,898 | 401,961 | 1,203,777 |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Depreciation & Amortisation | 591,633 | 3.378% | 572,299 | 643,640,000 | 598,913 | 612,756 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | 7.000 | -12.500% | 8.000 | 11.000 | 5.000 | 14.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | (2.008) | -- | 2.539 | 2.539 | (3.139) | (5.786) |
| NBV per share ($) | 9.050 | -- | 9.018 | 9.182 | 9.081 | 9.032 |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 493,537 |
| %Change | -14.405% |
| EPS / (LPS) | RMB 0.060 |
| NBV Per Share (¥) | RMB 9.099 |